国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
2期
293-296
,共4页
段直光%俞丽云%陈银朝%贾云琴%莫逆
段直光%俞麗雲%陳銀朝%賈雲琴%莫逆
단직광%유려운%진은조%가운금%막역
23G%微创%玻璃体切割术%玻璃体视网膜疾病
23G%微創%玻璃體切割術%玻璃體視網膜疾病
23G%미창%파리체절할술%파리체시망막질병
23 - gauge%micro - invasive%vitrectomy%vitreoretinopathy
目的:探讨23 G经结膜无缝合玻璃体切割系统在玻璃体视网膜疾病中的应用,观察其疗效及并发症情况。<br> 方法:回顾性分析2011-10/2013-10在我院行23 G 玻璃体切割术的患者46例48眼。其中,特发性黄斑裂孔8眼(16.7%),特发性黄斑前膜5眼(10.4%),玻璃体积血19眼(39.6%),糖尿病视网膜病变V~VI期8眼(16.7%),孔源性视网膜脱离8眼(16.7%)。观察手术前和手术后眼压变化情况、手术效果、时间、最佳矫正视力及术中、术后并发症等。术后随访1~12 mo。<br> 结果:所有病例均顺利完成手术,巩膜切口缝合组和未缝合组间术后1,7d;1mo眼压差异均无统计学意义(均为P>0.05);术后最佳矫正视力均有不同程度提高,与术前比较差异均有显著统计学意义(均为P<0.01)。手术时间70.12±7.86min;术后眼部刺激症状轻微,术后并发症少见。术中2眼套管滑脱,5眼结膜下出血,3眼结膜下气泡;所有病例在随访期间无严重并发症发生。<br> 结论:23 G玻璃体切割术具有微创、手术时间短等优点,术后恢复快,疗效好,并发症少,将其应用于治疗玻璃体视网膜病变是一种安全有效的微创手术方法。
目的:探討23 G經結膜無縫閤玻璃體切割繫統在玻璃體視網膜疾病中的應用,觀察其療效及併髮癥情況。<br> 方法:迴顧性分析2011-10/2013-10在我院行23 G 玻璃體切割術的患者46例48眼。其中,特髮性黃斑裂孔8眼(16.7%),特髮性黃斑前膜5眼(10.4%),玻璃體積血19眼(39.6%),糖尿病視網膜病變V~VI期8眼(16.7%),孔源性視網膜脫離8眼(16.7%)。觀察手術前和手術後眼壓變化情況、手術效果、時間、最佳矯正視力及術中、術後併髮癥等。術後隨訪1~12 mo。<br> 結果:所有病例均順利完成手術,鞏膜切口縫閤組和未縫閤組間術後1,7d;1mo眼壓差異均無統計學意義(均為P>0.05);術後最佳矯正視力均有不同程度提高,與術前比較差異均有顯著統計學意義(均為P<0.01)。手術時間70.12±7.86min;術後眼部刺激癥狀輕微,術後併髮癥少見。術中2眼套管滑脫,5眼結膜下齣血,3眼結膜下氣泡;所有病例在隨訪期間無嚴重併髮癥髮生。<br> 結論:23 G玻璃體切割術具有微創、手術時間短等優點,術後恢複快,療效好,併髮癥少,將其應用于治療玻璃體視網膜病變是一種安全有效的微創手術方法。
목적:탐토23 G경결막무봉합파리체절할계통재파리체시망막질병중적응용,관찰기료효급병발증정황。<br> 방법:회고성분석2011-10/2013-10재아원행23 G 파리체절할술적환자46례48안。기중,특발성황반렬공8안(16.7%),특발성황반전막5안(10.4%),파리체적혈19안(39.6%),당뇨병시망막병변V~VI기8안(16.7%),공원성시망막탈리8안(16.7%)。관찰수술전화수술후안압변화정황、수술효과、시간、최가교정시력급술중、술후병발증등。술후수방1~12 mo。<br> 결과:소유병례균순리완성수술,공막절구봉합조화미봉합조간술후1,7d;1mo안압차이균무통계학의의(균위P>0.05);술후최가교정시력균유불동정도제고,여술전비교차이균유현저통계학의의(균위P<0.01)。수술시간70.12±7.86min;술후안부자격증상경미,술후병발증소견。술중2안투관활탈,5안결막하출혈,3안결막하기포;소유병례재수방기간무엄중병발증발생。<br> 결론:23 G파리체절할술구유미창、수술시간단등우점,술후회복쾌,료효호,병발증소,장기응용우치료파리체시망막병변시일충안전유효적미창수술방법。
AIM: To investigate the application of 23-gauge trans-conjunctival sutureless vitrectomy system in the treatment of vitreoretinopathy disease and evaluate its therapeutic effect and complications. <br> METHODS: This retrospective study analyzed 46 patients ( 48 eyes ) who were performed 23 -gauge vitrectomy in this hospital from October 2011 to October 2013.Among all the eyes, idiopathic macular hole 8 appeared in eyes (16.7%), idiopathic macular epiretinal membrane presented in 5 eyes ( 10.4%), vitreous hemorrhage appeared in 19 eyes (39.6%);PDR (stage V-VI) occurred in 8 eyes ( 16.7%); and RRD 8 eyes (16.7%).Observation was made on intraocular pressure before and after surgery, surgical effects, surgical time, best corrected visual acuity, intraoperative and postoperative complications.The follow-up time lasted form 1-12mo. <br> RESULTS: All cases were successfully performed surgery and, there was no statistical difference in intraocular pressure between the two group ( P>0.05 ) after measuring it pre-operatively, 1, 7d and 1mo after surgery at each group.The postoperative best corrected visual acuity were improved to some different degree. The differences between postoperative and preoperative BCVA were statistically significant (P<0.01).The surgery time was 70.12 ±7.86min; few complications appeared after surgery.The intraoperative complications included intubation tube slippage in 2 eyes, subconjunctival hemorrhage in 5 eyes and bubble under conjunctivain in 3 eyes. No serious post -operative complication was observed during the follow-up time in all cases. <br> CONCLUSION: 23-gauge trans-conjunctival sutureless vitrectomy has advantages including micro-invasive cut and short surgical time.Due to its quick postoperative recovery, good curative effect and rare complication, it is an effective and safe surgical technique in the management of vitreoretinopathy disease.